Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Gene abnormality found for infant leukaemia:

This article was originally published in Clinica

Executive Summary

US scientists have identified a gene abnormality which could lead to an aggressive and deadly form of infant leukaemia. In a study involving 12 infants with acute lymphoblastic leukaemia, the most common form of cancer in children, researchers found that leukaemic cells from all the patients showed a specific abnormality in a gene called Ikaros as well as high levels of defective forms of the Ikaros protein. The study is published in the Proceedings of the National Academy of Sciences (January 19).

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT077301

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel